גאלבוס 50 מ"ג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

VILDAGLIPTIN 50 MG

Disponível em:

NOVARTIS PHARMA SERVICES AG

Código ATC:

A10BH02

Forma farmacêutica:

TABLETS

Via de administração:

PER OS

Fabricado por:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Grupo terapêutico:

VILDAGLIPTIN

Indicações terapêuticas:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Data de autorização:

2008-12-01